傅传刚 主任医师，教授
硕士招生类型：学术型；专业型
硕士招生专业：外科学（普外科）
博士招生类型：学术型；专业型
博士招生专业：外科学（普外科）
所在院系：附属东方医院
联系方式：fugang416@126.com
课题组链接：
研究方向
主要任职
科研业绩
大肠癌发病机理的基础研究；
结直肠癌的精准诊断、精准微创手术治疗
Basic research for the pathogenesisof colorectal cancer；
Accuratediagnosis of colorectal cancer, and precise laparoscopic surgery
美国结直肠医师学会荣誉委员
中国医师协会外科医师分会肛肠外科医师委员会主任委员
中国医师协会结直肠肿瘤专业委员会经自然腔道取标本手术（NOSES）专业委员会副主任委员
中国医师协会结直肠肿瘤分会外科委员会副主任委员
中国医师协会结直肠肿瘤专业委员会常务委员
中国中西医结合医学会大肠肛门病专业委员会顾问
上海市普外专业委员会大肠肛门病学组顾问
中国抗癌学会大肠癌专业委员会常委
中国医师协会结直肠分会常委
卫生部大肠癌规范化诊疗专家委员会委员
英国《Colorectal Disease》,美国《Disease of Colon and Rectum》，意大利《Techniques in Coloproctology》,《中华外科杂志》，《中华胃肠外科杂志》，《中华普通外科杂志》等编委。
American society of colorectalhonorary fellow
Director of the Chinese medicaldoctor association committee member surgeon branch of anorectal surgeons
Colorectal tumor professionalcommittee, China physicians association, and nature orifice specimen extractionsurgery (NOSES), deputy director of professional committee members
The Chinese medical doctorassociation branch of colorectal cancer surgery committee, deputy director ofthe committee members
Standing committee of colorectaltumor professional committee, China physicians association
The anus disease combine traditionalChinese and western medicine medical association professional committee ofChina
Consultants of Shanghai generalprofessional committee and anus epidemiology group
society member of Colorectal cancerprofessional committee
The standing committee of the Chinesemedical doctor association colorectal section
The ministry of health of colorectalcancer diagnostic expert committee
Editorsof
国自然项目：
1、2017年，国自然面上项目，IncRNA-SLC25A25-AS1介导直肠癌放疗抵抗的作用机制研究，54万。
2、2015年，国自然面上项目，IGF-1促进多药耐药蛋白表达介导直肠癌放疗抵抗的分子机制，57万。
论文：
1.a scoringsystem to predict development of bone metastasis after radical resection ofcolorectal cancer. Anticancer research. 2017.
2.systemic analysis ofdifferent colorectal cancer cell lines and TCGA datasets identifiedIGF-1R/EGFR-PPAR-CASPASE axis as important indicator for randiotherapysensitivity. Gene. 2017.
3.miR-320b suppressescell proliferation by targeting c-Myc in human colorectal cancer cells. BMCCancer. 2015.
4.Endoplasmic reticulumribosome-binding protein 1, RRBP1, promotes progression of colorectal cancerand predicts an unfavourableprognosis. British journal of cancer.2015
5.More advanced oraggressive colorectal cancer is associated with a higher incidenceof‘high-grade intraepithelial neoplasia’ on biopsy-based pathologicalexamination, Tech Coloproctol ,2012.
6.Red and processed meatintake and risk of colorectal adenomas: a meta-analysis of observationalstudies,2012,Int.J.Cancer.
7. DNA topoisomeraseⅡalpha: afavorable prognostic factor in colorectal caner. Int J Colorectal Dis 2011.
8. Suppression of lung cancermetastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancercells, Molecular Biology Reports,
9. Residual skin tags followingProcedure for Prolapse and Hemorrhoids should be differentiated fromrecurrence,World J Surg, 2011.
10. Rectal Perforation AfterProcedure for Prolapse and Hemorrhoids: Possible Causes. Diseases of the Colon& Rectum, 2010.
11. Diagnosis and treatment ofdiffuse cavernous hemangioma of the rectum: report of 17 cases. World J Surg,2010.
12.Patterns of lymph node metastasis are different in colon and rectal carcinomas, World J Gastroenterol, 2010.
